Rajnish Mago, MD
Director, Mood Disorders Program
Associate Professor, Psychiatry and Human Behavior

Contact Dr. Mago

833 Chestnut East, Suite 210
Philadelphia, PA 19107

(215) 955-9474
(215) 503-5698 (fax)

Medical School
King George's Medical College, University of Lucknow, Lucknow, India (1988)

Residency
University of Pennsylvania, Philadelphia, PA (1998)

Board Certification
American Board of Psychiatry and Neurology, Certified in Psychiatry
American Board of Psychiatry and Neurology, Psychosomatic Medicine

University Appointment
Assistant Professor, Psychiatry and Human Behavior

Research and Clinical Interests
Evaluation and treatment of Mood disorders including Depressive disorders ("depression") and Bipolar disorder; Evaluation and treatment of Treatment-resistant mood disorders; Evaluation and treatment of side effects of medications, including Excessive sweating; Psychotherapy for the treatment of chronic (long-standing) clinical depression; Second-opinion consultations regarding diagnosis and treatment of Mood disorders; Novel approaches to identification and assessment of side effects of medications; Novel approaches to treatment of various side effects of psychiatric medications; Clinical trials of new medications for the treatment of Mood disorders; Practical strategies for the teaching and practice of evidence-based medicine

Publications

1. Glycopyrrolate for antidepressant-associated excessive sweating
2. Identifying potential adverse effects by patients' ratings: A proof-of-concept study of a novel approach
3. Antidepressants and the risk of abnormal bleeding during spinal surgery: A case-control study
4. Reducing CYP450 drug interactions caused by antidepressants
5. Efficacy of drugs in bipolar depression: What the data show
6. Practical implications of a study on treating chronic insomnia
7. Proposed strategies for successful clinical management with aripiprazole
8. Medically serious adverse effects of newer antidepressants
9. Urinary retention associated with ziprasidone: A case report
10. Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients [6]
11. An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression
12. Recurrent priapism associated with use of aripiprazole [2]
13. Tardive dystonia-associated prescription of aripiprazole
14. Anxiety in medically ill patients
15. Psycho-oncology: Review and update
16. Zonisamide-induced suicidal ideation
17. Periodic restless legs syndrome associated with quetiapine use: A case report [6]
18. Depression, cognition, and anxiety among postmenopausal women with breast cancer
19. Second-generation antipsychotics and the metabolic syndrome
20. Injection site pain with long-acting risperidone [2] (multiple letters)

View All Publications